Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders

NCT03602235 is registered in ClinicalTrials.gov with Christopher Strouse as lead sponsor.

NCT NCT03602235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03602235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders
Lead sponsor
Christopher Strouse
Phase
Phase 1
Overall status
Completed
Start date
March 5, 2019
Completion date
September 3, 2025
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma